United Therapeutics Corp (NASDAQ:UTHR)
| 241.53 Delayed Data As of Dec 08 |  -0.54 / -0.22%Today’s Change | 204.44 Today|||52-Week Range 283.09 | -13.15% Year-to-Date |
Latest UTHR News | Press Releases
| Insider Sell Alert: EVP & GENERAL COUNSEL Paul Mahon Sells 6,000 Shares of United ... Dec 08 / GuruFocus News - Paid Partner Content | United Therapeutics (UTHR) Up 5.2% Since Last Earnings Report: Can It Continue? Dec 01 / Zacks.com - Paid Partner Content |
| Theravance Bio (TBPH) Up 2.5% Since Last Earnings Report: Can It Continue? Dec 07 / Zacks.com - Paid Partner Content |
Today’s Trading
| Previous close | 242.07 |
| Today’s open | 242.64 |
| Day’s range | 240.09 - 244.09 |
| Volume | 12,579 |
| Average volume (3 months) | 286,910 |
| Market cap | $11.3B |
Data as of 3:59pm ET, 12/08/2023
Growth & Valuation
| Earnings growth (last year) | +50.84% |
| Earnings growth (this year) | +24.96% |
| Earnings growth (next 5 years) | +0.67% |
| Revenue growth (last year) | +14.88% |
| P/E ratio | 13.3 |
| Price/Sales | 6.97 |
| Price/Book | 2.31 |
Competitors
Data as of 4:00pm ET, 12/08/2023
Financials
| Next reporting date | February 21, 2024 |
| EPS forecast (this quarter) | $4.33 |
| Annual revenue (last year) | $1.9B |
| Annual profit (last year) | $727.3M |
| Net profit margin | 37.56% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Silver Spring, Maryland |
Forecasts
